Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Endometrial+Neoplasms%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
/vufind/Search/Results?lookfor=%22Endometrial+Neoplasms%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
Search /vufind/Search2/Results?lookfor=%22Endometrial+Neoplasms%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
PubPharm (2.395)
1
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer : a pilot study
enthalten in:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
| 2024
von
Shang, X.
|
Su, H.
|
Chen, X.
| +5
Wird geladen...
2
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer : A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone : A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus : Sentinel Lymph Node Sampling Versus Systematic Pelvic Lymphadenectomy on the Prognosis for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus Before Surgery: a Non-inferiority Randomized Controlled Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer : Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer: a Prospective Open-label Single-arm Clinical Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer : Gonadotropin-releasing Hormone Agonist Combined With Letrozole Compared With Megestrol Acetate or Medroxyprogesterone Acetate Alone as Fertility-sparing Treatment in Early Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
(VELA) Study of BLU-222 in Advanced Solid Tumors : A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients : Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Non-obese Progestin-insensitive Early-stage Endometrial Cancer and Atypical Hyperplasia Patients With Conservative Treatment
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity : Is Pipelle Biopsy of Benefit in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity?
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer : Multicenter, Open-label, Randomized, Controlled Study to Test the Utility of Electronic Patient-reported Outcome (ePRO) Monitoring in Patients With Unresectable Advanced Cancers or Metastatic/Recurrent Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[240]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
2.388
Aufsätze
2.015
E-Ressourcen
2.012
E-Artikel
376
Gedruckte Aufsätze
7
Bücher
4
Gedruckte Bücher
3
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
1.073
ClinicalTrials.gov
199
International journal of gynecological cancer :...
103
Gynecologic oncology
84
Journal of gynecologic oncology
40
Cancer causes & control
30
WHO International Clinical Trials Registry Plat...
27
European radiology
19
BMC cancer
18
Der Gynäkologe
17
International journal of gynecological cancer
15
Obstetrics & gynecology
15
Ultrasound in obstetrics & gynecology : the off...
14
Zhonghua fu chan ke za zhi
12
Anticancer research
12
Obstetrics & gynecology science
12
The journal of minimally invasive gynecology
11
Frontiers in oncology
11
International journal of cancer
10
Archives of gynecology and obstetrics
10
European journal of gynaecological oncology
Alle anzeigen ...
weniger ...
Thema
1.264
Endometrial Neoplasms
1.103
610
848
Study Type: Interventional
608
Journal Article
402
Endometrial neoplasms
364
Recruitment Status: Recruiting
337
Recruitment Status: Completed
277
endometrial neoplasms
264
Phase: Phase 2
243
Study Type: Observational
230
Carcinoma
190
Endometrial Neoplasms - pathology
151
Ovarian Neoplasms
151
Recruitment Status: Active, not recruiting
149
Phase: Phase 1
124
Neoplasms
119
Medical Condition: Endometrial Cancer
114
Uterine Cervical Neoplasms
100
Recruitment Status: Not yet recruiting
84
Research Support, Non-U.S. Gov't
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.372
2000-
5
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.267
Englisch
62
Chinesisch
44
Deutsch
11
Spanisch
10
Französisch
3
Koreanisch
3
Portugiesisch
2
Unbestimmt
1
Persisch
1
Russisch
1
Ukrainisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...